Population
Individuals in whom the diagnosis of Duchenne or Becker muscular dystrophy has been confirmed
Design
Guideline
Loading...
Supports routine cardiovascular evaluation in DMD/BMD patients; extends evidence-based cardiomyopathy surveillance guidelines.
This policy statement provides recommendations for the cardiovascular evaluation of patients with Duchenne or Becker muscular dystrophy to proactively address the risk of cardiomyopathy and heart failure.
A 2005 study studied Duchenne or Becker muscular dystrophy. Cardiovascular evaluation recommendations was evaluated. This policy statement provides recommendations for optimal cardiovascular evaluation for individuals diagnosed with Duchenne or Becker muscular dystrophy.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: